RPG Life Sciences Ltd - 532983 - Clarification sought from RPG Life Sciences Ltd
The Exchange has sought clarification from RPG Life Sciences Ltd on April 22, 2021, with reference to Movement in Volume.The reply is awaited.22-04-2021
22-04-2021
RPG Life Sciences Ltd - 532983 - Shareholding for the Period Ended March 31, 2021
RPG Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here20-04-2021
RPG Life Sciences Ltd - 532983 - Compliance - Certificate Under Regulation 40(9)
We enclose herewith certificate issued by Practicing Company Secretary, pursuant to Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half year ended March 31, 2021. Kindly take the same on record19-04-2021
RPG LIFE SCIENCES LTD. - 532983 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We wish to inform you that on April 10, 2021, we have received application for loss of share certificate through Link Intime India Private Limited ('RTA'). A copy of email received from RTA is enclosed herewith for your reference. Kindly take the same on record.10-04-2021
RPG LIFE SCIENCES LTD. - 532983 - Compliance Certificate For The Period Ended March 31, 2021
As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to share transfer facility are maintained during the period October 1, 2020 to March 31, 2021 (both days inclusive) by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited, which is registered as Registrar & Share Transfer Agent in Category-I with the Securities and Exchange Board of India vide Registration Number : INR000004058.09-04-2021
RPG LIFE SCIENCES LTD. - 532983 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Rajesh ShirambekarDesignation :- Company Secretary and Compliance Officer09-04-2021
RPG LIFE SCIENCES LTD. - 532983 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith certificate dated April 8, 2021 issued by Link Intime India Private Limited, Registrar and Share Transfer Agents, confirming compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. Kindly take the same on record.09-04-2021
RPG LIFE SCIENCES LTD. - 532983 - Closure of Trading Window
This is to inform you that pursuant to the 'Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders' of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives shall remain closed from Thursday, April 1, 2021 until 48 hours after the declaration of financial results by the Company for the quarter and year ending March 31, 2021. The date of Board Meeting of the Company for consideration and declaration of the Financial Results for the quarter and year ending March 31, 2021 will be intimated in due course. Kindly take this information on record.31-03-2021
RPG LIFE SCIENCES LTD. - 532983 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In terms of the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the newspaper publications with respect to Unaudited Financial Results for the quarter and nine months ended December 31, 2020. Kindly take this information on record.27-01-2021
RPG LIFE SCIENCES LTD. - 532983 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith a copy of press release with respect to Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2020. Kindly take the above on record.25-01-2021